Biocon arm Syngene names Sibaji Biswas as new Chief Financial Officer

Sibaji Biswas will succeed M.B. Chinappa, current CFO, who will stay within the Biocon Group of Companies and join Biocon Biologics India Ltd. in a new role.

Bengaluru: Syngene International Limited, a global contract research organization, announced the appointment of Sibaji Biswas as Chief Financial Officer and member of the Executive Committee with effect from December 18, 2019.

He will succeed M.B. Chinappa, current CFO, who will stay within the Biocon Group of Companies and join Biocon Biologics India Ltd. in a new role.

Sibaji Biswas brings more than twenty years of extensive experience in finance and related functions. His prior experience includes eleven years at Vodafone as well as roles in Fascel Telecommunications, Jhagadia Copper and the ABP Group. In his most recent role, he was CFO and Board Member for Vodafone Romania.

With a B.Tech from IIT Kharagpur, Sibaji is a Chartered Financial Analyst from ICFAI and holds an MBA (Finance) from the University of Calcutta. He has also completed Management Development Programs at the Indian Institute of Management (Ahmedabad) and London Business School.

Read Also: Syngene reports robust 11% YOY revenue growth in Q2 FY20

Jonathan Hunt, CEO, Syngene International said, “We are delighted to welcome Sibaji to Syngene. He brings operational experience combined with a deep finance background which will be extremely valuable to the company as it enters the next phase of growth. We are indebted to Chinappa for the pivotal part he has played in successfully stewarding Syngene through its formative years and in establishing the sound foundations for our continued future growth."

"The Syngene International Board takes this opportunity to place on record their thanks to Chinappa for the major contribution he has made to the development of the company since 2008 and wishes him every success in his new role,” Hunt added.

Read Also: Syngene, Narayana Health, AIF launch CHAMPS- unique initiative to prevent, manage early onset of NCDs